Highlights
NASDAQ: AVXL       Anavex Lf SC
Last Price Today's Change   Day's Range   Trading Volume
4.09   -0.15 (3.54%)  4.07 - 4.36  609,400

Overview

 
Avg Volume (4 weeks):630,155
4 Weeks Range:3.05 - 4.39
4 Weeks Price Volatility (%):
77.61%
52 Weeks Range:2.20 - 6.31
52 Weeks Price Volatility (%):
45.99%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company operating in the United States. It is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer's disease, other central nervous systems (CNS) diseases, pain and several types of cancer. The lead compound of the company is ANAVEX 2-73 which is developed to treat Alzheimer's disease, Parkinson's disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome. The research and development pipeline of the company includes one clinical drug candidate and several compounds in various stages of the pre-clinical study.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3678  4515  465  189 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 2.13+0.74 
 SHIP 0.13-0.011 
 HTZ 0.56-2.28 
 GE 6.80+0.39 
 BAC 24.28+1.62 
 XLF 23.06+1.14 
 AAL 11.14+1.44 
 SPY 299.08+3.64 
 UAL 29.54+4.14 
 MARK 2.87+0.61 
Partners & Brokers